What if the tiny silkworm, best known for making silk, could help create life-saving medicines and vaccines? Sounds like science fiction? Meet Loopworm, a bold Indian biotech startup that’s turning this crazy idea into reality — and they just scored $3.25 million to make it happen faster than anyone imagined.
Loopworm isn’t doing biotech the usual way. Instead of giant, expensive machines, they use silkworms as living factories to produce complex proteins needed in diagnostics and animal vaccines. It’s cheaper, faster, and way more eco-friendly than traditional methods that rely on genetically engineered microbes and massive steel tanks.
Founded by two IIT Roorkee grads, Ankit Alok Bagaria and Abhi Gawri, Loopworm’s “silkworm bioreactor” approach is shaking up the protein production industry. And now, with fresh funding led by WaterBridge Ventures and Japan’s ENRISSION INDIA CAPITAL, they’re ready to scale up big time.
The cash injection will turbocharge their production, help build new partnerships, and get their life-changing protein products into markets with less red tape — meaning faster access to affordable healthcare solutions.
If Loopworm succeeds, this tiny insect could disrupt global medicine manufacturing forever, slashing costs and environmental impact along the way.
